TABLE 6.
Genotoxicity of CDPDP on blood lymphocytes was assessed using comet measurements.
| Sample | Comet length (µm) | Head length (µm) | Tail length (µm) | % DNA in head | % DNA in tail | Tail moment (µm) |
|---|---|---|---|---|---|---|
| Control | 42.6 ± 3.1 | 36.7 ± 2.5 | 5.9 ± 0.3 | 86.1 ± 2.8 | 13.9 ± 1.8β | 0.11 ± 0.03β |
| EMS (20 μg/ml) | 46.0 ± 3.6 | 31.0 ± 2.7 | 15.0 ± 3.4 | 67.39 ± 8.5 | 32.61 ± 5.8¥ | 1.37 ± 0.11¥ |
| CDPDP (10 μg/ml) | 40.4 ± 4.2 | 35.9 ± 1.8 | 4.5 ± 0.5 | 88.8 ± 2.1 | 11.2 ± 1.3β | 0.11 ± 0.04 β |
| CDPDP (20 μg/ml) | 40.1 ± 2.7 | 32.5 ± 1.4 | 7.6 ± 1.0 | 81.1 ± 2.4 | 18.9 ± 1.3¥β | 0.36 ± 0.04¥β |
Values are expressed as Mean ± SD (n = 3). Means with symbol “β” indicate non-significant difference from control; “¥” from EMS, treated group according to Kruskal–Wallis test at p < 0.05.